A detailed history of Acorn Creek Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Acorn Creek Capital LLC holds 2,299 shares of NVO stock, worth $233,900. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,299
Previous 2,140 7.43%
Holding current value
$233,900
Previous $306 Million 10.38%
% of portfolio
0.15%
Previous 0.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$119.07 - $145.42 $18,932 - $23,121
159 Added 7.43%
2,299 $274 Million
Q2 2024

Jul 18, 2024

BUY
$122.71 - $146.91 $15,461 - $18,510
126 Added 6.26%
2,140 $306 Million
Q1 2024

Apr 24, 2024

BUY
$102.11 - $135.92 $205,649 - $273,742
2,014 New
2,014 $259 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Acorn Creek Capital LLC Portfolio

Follow Acorn Creek Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acorn Creek Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acorn Creek Capital LLC with notifications on news.